EUVIMEDEUVIMED entdecken
Open Access

Reproductive capacity after gender-affirming testosterone therapy

Hadrian M Kinnear iD, Molly B Moravek iD

Human Reproduction · 03.10.2023 · 38 (10) · 1872-1880

DOI: 10.1093/humrep/dead158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 12.08.2023. Verfasst von Hadrian M Kinnear und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Fertility Preservation, Transgender Persons. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transgender and nonbinary people with female birth sex may utilize testosterone therapy for masculinization. Individuals interested in reproduction using their own gametes should be offered fertility preservation prior to starting testosterone. However, logistical and practical barriers prevent many from accessing fertility preservation options prior to starting testosterone. Some of these transmasculine and nonbinary individuals may later become interested in carrying a pregnancy or using their oocytes for reproduction after being on testosterone. Many questions remain about the reproductive impact of long-term masculinizing testosterone therapy. Emerging literature has documented pregnancies and successful assisted reproduction for some people after taking testosterone, but it is not known whether individuals can expect these successful outcomes. Testosterone appears to impact the reproductive tract, including the ovaries, uterus, and fallopian tubes, but the reversibility and functional impact of these changes also remain unclear. A greater understanding of the impact of masculinizing testosterone on reproductive capacity remains a priority area for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationTransgender PersonsPregnancyHumansFemaleTestosteroneReproductionOvaryMale

Stichwörter der Autor:innen

fertilitygender-affirming hormonesnonbinaryreproductiontestosteronetransgendertransmasculine

Substanzen

Testosterone

Autor:innen und Institutionen

  • Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA.
  • Medical Scientist Training Program, University of Michigan, Ann Arbor, MI, USA.
  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Urology, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Hadrian M Kinnear, Molly B Moravek

Förderung

  • NICHD NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Kinnear, H. M., & Moravek, M. B. (2023). Reproductive capacity after gender-affirming testosterone therapy. Human Reproduction, 38(10), 1872-1880. https://doi.org/10.1093/humrep/dead158

Vancouver

Kinnear HM, Moravek MB. Reproductive capacity after gender-affirming testosterone therapy. Human Reproduction. 2023;38(10):1872-1880. doi:10.1093/humrep/dead158

BibTeX
@article{Kinnear2023,
  author = {Kinnear, Hadrian M and Moravek, Molly B},
  title = {Reproductive capacity after gender-affirming testosterone therapy},
  journal = {Human Reproduction},
  year = {2023},
  volume = {38},
  number = {10},
  pages = {1872--1880},
  doi = {10.1093/humrep/dead158}
}
Kostenlos starten →